Correlation Between PIRS Old and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both PIRS Old and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PIRS Old and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PIRS Old and Stoke Therapeutics, you can compare the effects of market volatilities on PIRS Old and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PIRS Old with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PIRS Old and Stoke Therapeutics.
Diversification Opportunities for PIRS Old and Stoke Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between PIRS and Stoke is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding PIRS Old and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and PIRS Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PIRS Old are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of PIRS Old i.e., PIRS Old and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between PIRS Old and Stoke Therapeutics
Given the investment horizon of 90 days PIRS Old is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, PIRS Old is 1.56 times less risky than Stoke Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,503 in Stoke Therapeutics on November 2, 2024 and sell it today you would lose (404.00) from holding Stoke Therapeutics or give up 26.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 71.84% |
| Values | Daily Returns |
PIRS Old vs. Stoke Therapeutics
Performance |
| Timeline |
| PIRS Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Stoke Therapeutics |
PIRS Old and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PIRS Old and Stoke Therapeutics
The main advantage of trading using opposite PIRS Old and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PIRS Old position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| PIRS Old vs. Adaptimmune Therapeutics Plc | PIRS Old vs. Mereo BioPharma Group | PIRS Old vs. PDS Biotechnology Corp | PIRS Old vs. Leap Therapeutics |
| Stoke Therapeutics vs. Surrozen | Stoke Therapeutics vs. Armata Pharmaceuticals | Stoke Therapeutics vs. Pasithea Therapeutics Corp | Stoke Therapeutics vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |